# A Nomogram for Evaluating Significant Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection

> **NCT05560503** · — · COMPLETED · sponsor: **Xiangya Hospital of Central South University** · enrollment: 259 (actual)

## Conditions studied

- Liver Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05560503
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2022-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05560503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05560503, "A Nomogram for Evaluating Significant Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05560503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*